Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 257 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1262. Clear
Clear
Q2
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Pharmacy, Science/Technology, Trade (domestic/foreign)
View →
Q2
ARNOLD & PORTER KAYE SCHOLER LLP for NEURELIS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $10,000.00 income
Health Issues
View →
Q2
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Pharmacy
View →
Q2
ASSOCIATION FOR CLINICAL ONCOLOGY for ASSOCIATION FOR CLINICAL ONCOLOGY
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate
Medicare/Medicaid, Health Issues, Tobacco, Budget/Appropriations
View →
Q2
THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q2
THE KPM GROUP DC LLC for INOZYME PHARMA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $20,000.00 income
Pharmacy
View →
Q2
THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q2
ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid
View →
Q2
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q2
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q2
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q2
LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $30,000.00 income
Health Issues
View →
Q2
LMH STRATEGIC SOLUTIONS for PTC THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $30,000.00 income
Health Issues
View →
Q2
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $20,000.00 income
Health Issues
View →
Q2
DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
RR
THE KPM GROUP DC LLC for INOZYME PHARMA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts
Pharmacy
View →
Q2
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Health Issues
View →
1A
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues
View →
Q1
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q1
STEALTH BIOTHERAPEUTICS INC. for STEALTH BIOTHERAPEUTICS INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate
Health Issues
View →
Q1
YC CONSULTING, LLC for PATIENTS RISING NOW
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $80,000.00 income
Health Issues
View →
Q1
ALSTON & BIRD LLP for ST. JUDE CHILDREN'S RESEARCH HOSPITAL
1st Quarter (Jan 1 - Mar 31) 2025 · Tennessee · House · Senate
Health Issues
View →
Q1
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
SPARK THERAPEUTICS, INC. for SPARK THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate
Medicare/Medicaid, Health Issues
View →
Previous Page 9 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem